ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Omron prescribes telemedicine for growth in the 'new normal'

Remote heart monitors offer new profit driver as sales stagnate

Omron's HeartGuide is the first FDA-approved wearable blood pressure monitor.   © Reuters

KYOTO -- Japanese electronics manufacturer Omron has begun laying the groundwork for growth after the coronavirus as telemedicine looks poised to become part of the medical sector's "new normal."

"We're prepared to seize new growth opportunities that will accelerate after the coronavirus shock," President Yoshihito Yamada said in an earnings briefing last week conducted via teleconference.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more